Brief: Southpoint Capital Advisors- Southpoint Controls 2.7 Million Common Shares, 8% Of Outstanding Common Shares Of Fennec
Dec 26 (Reuters) - Fennec Pharmaceuticals Inc FENC.O: SOUTHPOINT CAPITAL ADVISORS- SOUTHPOINT CONTROLS 2.7 MILLION COMMON SHARES, 8% OF OUTSTANDING COMMON SHARES OF FENNEC Source text: ID:nGNX75l1C5 Further company coverage: FENC.O ((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Fennec Pharmaceuticals
See all newsFennec Pharmaceuticals Inc. reports results for the quarter ended June 30 - Earnings Summary
Fennec Pharmaceuticals Q2 sales rise on PEDMARK demand
Fennec Pharmaceuticals Inc. expected to post earnings of 1 cent a share - Earnings Preview
Fennec Pharmaceuticals Q1 sales rise 73% on PEDMARK demand
U.S. STOCKS ON THE MOVE-UnitedHealth, Intel, Apple